Milan-based biotech Aptadir Therapeutics raises $45M seed round
AMilan-based biotech company developing novel treatments for difficult to treat genetic conditions has raised a $45m seed round, it said today.Theseed round investment in Aptadir Therapeutics is one o...
Tech.eu2 min read